Published in Vaccine on October 19, 2012
Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol (2014) 0.90
Transcriptional activation of antioxidants may compensate for selenoprotein deficiencies in Amblyomma maculatum (Acari: Ixodidae) injected with selK- or selM-dsRNA. Insect Mol Biol (2014) 0.83
Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol (2015) 0.83
Helicobacter pylori vaccination: is there a path to protection? World J Gastroenterol (2014) 0.78
In Silico Design of a Chimeric Protein Containing Antigenic Fragments of Helicobacter pylori; A Bioinformatic Approach. Open Microbiol J (2016) 0.76
Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines. Hum Vaccin Immunother (2016) 0.75
Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease. PLoS One (2014) 0.75
Mucin dynamics and enteric pathogens. Nat Rev Microbiol (2011) 4.23
MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog (2009) 1.69
Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology (2007) 1.43
Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol (2008) 1.24
The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut (2011) 1.13
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine (2004) 1.12
Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10
Localized suppression of inflammation at sites of Helicobacter pylori colonization. Infect Immun (2011) 0.98
Saponin-adjuvanted particulate vaccines for clinical use. Methods (2006) 0.95
TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. Int Immunol (2004) 0.93
Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens. Vaccine (2010) 0.92
M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. Infect Immun (2009) 0.91
Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine. Clin Vaccine Immunol (2011) 0.87
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines. Vaccine (2004) 0.86
Helicobacter pylori defense against oxidative attack. Am J Physiol Gastrointest Liver Physiol (2011) 0.86
Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology (2009) 0.85
Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infection. Helicobacter (2008) 0.84
Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression. J Clin Invest (2016) 0.83
Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. Arthritis Rheumatol (2015) 0.83
Vaccinating against Helicobacter pylori: dissecting the mechanism. Gastroenterology (2011) 0.82
Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals. Vet Immunol Immunopathol (2008) 0.81
Mucosal vaccination: lung versus nose. Vet Immunol Immunopathol (2011) 0.81
PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population. Anticancer Res (2012) 0.79
Helicobacter pylori flagella: antigenic profile and protective immunity. FEMS Immunol Med Microbiol (2007) 0.78
Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. Vaccine (2010) 0.78
Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori. Vaccine (2008) 0.77
Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression. Helicobacter (2013) 0.77
A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori. FEMS Immunol Med Microbiol (2009) 0.76
Did transmission of Helicobacter pylori from humans cause a disease outbreak in a colony of Stripe-faced Dunnarts (Sminthopsis macroura)? Vet Res (2011) 0.76
Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract. Gut Microbes (2010) 0.76
ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. Hum Vaccin Immunother (2015) 0.75
Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge. Helicobacter (2008) 0.75
Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens. Methods Mol Biol (2012) 0.75
Increased Helicobacter felis colonization in male 129/Sv mice fails to suppress gastritis. Gut Microbes (2011) 0.75
Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity. Inflamm Bowel Dis (2017) 0.75
Mucosal immunology down under: Special Interest Group in Mucosal Immunology workshop, Australasian Society for Immunology, Sydney, Australia, 2 December 2007. Immunol Cell Biol (2008) 0.75
Exploring local immune responses to vaccines using efferent lymphatic cannulation. Expert Rev Vaccines (2015) 0.75